1. RECURRENCE RATE OF CYSTOID MACULAR EDEMA WITH TOPICAL DORZOLAMIDE TREATMENT AND ITS RISK FACTORS IN RETINITIS PIGMENTOSA.
- Author
-
Shimokawa S, Murakami Y, Fujiwara K, Funatsu J, Nakatake S, Koyanagi Y, Akiyama M, Yoshida N, Takeda A, Ikeda Y, and Sonoda KH
- Subjects
- Administration, Topical, Carbonic Anhydrase Inhibitors administration & dosage, Female, Follow-Up Studies, Humans, Incidence, Japan epidemiology, Macular Edema drug therapy, Macular Edema etiology, Male, Middle Aged, Prospective Studies, Recurrence, Retinitis Pigmentosa diagnosis, Risk Factors, Time Factors, Macula Lutea growth & development, Macular Edema epidemiology, Retinitis Pigmentosa complications, Risk Assessment methods, Sulfonamides administration & dosage, Thiophenes administration & dosage, Tomography, Optical Coherence methods, Visual Acuity
- Abstract
Purpose: To investigate the rate of the recurrence of cystoid macular edema (CME) secondary to retinitis pigmentosa (RP) after the initiation of topical dorzolamide and the recurrence risk factors., Methods: We retrospectively analyzed the data of RP patients at Kyushu University Hospital. We included patients who showed a treatment response to 1.0% topical dorzolamide. The day of treatment initiation was set as the baseline. Topical dorzolamide treatment was continued during the follow-up. The recurrence of CME (defined as a >20% increase in central subfield thickness compared to previous visit, or a central subfield thickness value that exceed baseline value) was evaluated at each follow-up visit. Risk factors for RP-CME recurrence were analyzed by Cox proportional hazards modeling. A Kaplan-Meier survival analysis was used to evaluate the time to recurrent RP-CME., Results: Forty RP-CME patients showed a treatment response to topical dorzolamide. During the mean 3.9-year follow-up, 14 patients exhibited recurrence; its rate was 15.6%, 34.7%, and 48.7% at 1, 3, and 5 years, respectively. A high baseline central subfield thickness was significantly associated with recurrent (hazard ratio 1.11, 95% CI: 1.05-1.18, P = 0.0004)., Conclusion: The recurrence rate of RP-CME increased with time. A high baseline central subfield thickness value was a risk factor for recurrence.
- Published
- 2022
- Full Text
- View/download PDF